Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is -31.76%.
Reported quarterly EBITDA margin; no daily interpolation.
Limited quarterly history available
EBITDA Margin needs at least three reported quarters before a meaningful chart is shown.
EBITDA MARGIN
-31.76%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Contineum Therapeutics, Inc.
Market Cap
$473.09M
EBITDA Margin
-31.76%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$473.29M
EBITDA Margin
-26.24%
TTM Avg
-39.04%
3Y Avg
-67.96%
5Y Avg
-45.86%
Market Cap
$474.59M
EBITDA Margin
-3.52%
TTM Avg
-5.19%
3Y Avg
-11.78%
5Y Avg
-23.46%
Market Cap
$475.07M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$475.52M
EBITDA Margin
-41.77%
TTM Avg
-67.13%
3Y Avg
-207.81%
5Y Avg
-270.93%
Market Cap
$470.65M
EBITDA Margin
-47.32%
TTM Avg
-54.85%
3Y Avg
-73.89%
5Y Avg
-85.45%
Market Cap
$486.67M
EBITDA Margin
-9.71%
TTM Avg
-10.19%
3Y Avg
-20.82%
5Y Avg
-63.11%
Market Cap
$489.65M
EBITDA Margin
21.12%
TTM Avg
19.78%
3Y Avg
18.26%
5Y Avg
11.49%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | $473.09M | -31.76% | N/A | N/A | N/A |
| Alpha Teknova, Inc. (TKNO)vs › | $473.29M | -26.24% | -39.04% | -67.96% | -45.86% |
| Cerus Corporation (CERS)vs › | $474.59M | -3.52% | -5.19% | -11.78% | -23.46% |
| Kamada Ltd. (KMDA)vs › | $471.36M | 22.80% | 21.92% | 17.96% | 15.83% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $475.07M | N/A | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $475.52M | -41.77% | -67.13% | -207.81% | -270.93% |
| Sight Sciences, Inc. (SGHT)vs › | $470.65M | -47.32% | -54.85% | -73.89% | -85.45% |
| Evolus, Inc. (EOLS)vs › | $486.67M | -9.71% | -10.19% | -20.82% | -63.11% |
| Puma Biotechnology, Inc. (PBYI)vs › | $489.65M | 21.12% | 19.78% | 18.26% | 11.49% |
| NRC Health (NRC)vs › | $453.45M | 21.99% | 25.40% | 28.98% | 31.97% |
Gross Margin
0.0%
EBITDA Margin
-31.8%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2023-06-30 | 77.96% |
